Loading insider details...
Beta
Latest Form 4 (Sep 22, 2026): Grant/Award of 107 ALNY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 107 | n/a |
| Mar 6, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Sale | 135 | $43.1K |
| Mar 5, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 13,844 | n/a |
| Mar 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 5,921 | n/a |
| Feb 18, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 14,209 | n/a |
| Jan 14, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 19,003 | n/a |
| Dec 1, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 839 | $100.0K |
| Nov 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 650 | $27.4K |
| Oct 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 3,860 | n/a |
| Aug 19, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 14,252 | n/a |